Solid Biosciences

SLDBSolid Biosciences

About Solid Biosciences

Solid Biosciences (NASDAQ:SLDB) focuses on developing therapies for Duchenne muscular dystrophy (DMD) and other neuromuscular diseases. With a dedication to improving the lives of patients affected by these conditions, the company's operations span research, development, and advocacy within the neuromuscular disease community. Solid Biosciences is driven by a commitment to advancing scientific research and therapy options for those facing DMD, aiming to address the unmet medical needs of the Duchenne community through innovative solutions and partnerships. Their objectives revolve around progressing their lead gene therapy candidate through clinical trials and ultimately delivering transformative treatments to patients and their families.

What is SLDB known for?

Snapshot

Public US

Ownership

2013

Year founded

Employees

Massachusetts, United States

Head office

Loading Map...

Operations

All Locations

United States

Products and/or services of Solid Biosciences

Sarepta Therapeutics, Inc. acquired the global rights to SGT-001, a gene therapy for Duchenne Muscular Dystrophy, aiming to address the underlying genetic cause and promote dystrophin production.
Development of novel manufacturing processes for adeno-associated virus (AAV) vectors, enhancing the scalability and efficiency of gene therapy production.
Research into next-generation gene therapy candidates, focusing on innovative approaches for treating Duchenne Muscular Dystrophy and other genetic diseases.
Collaboration with academic and industry partners to discover and develop targeted therapies for muscular dystrophies, leveraging expertise in muscle biology.
Implementation of patient-centric programs to support the Duchenne Muscular Dystrophy community, offering resources, education, and access to new therapies.
Engagement in scientific forums and conferences to share findings, fostering collaboration and driving forward the research in gene therapy and muscular dystrophy treatment.